Browsing by Author Huang, Yunhong
Showing results 1 to 3 of 3
Issue Date |
Title |
Author(s) |
Aug-2022 |
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthere (R)) in combination with CHOP in patients with previously untreated CD20-positive diffuse large B-cell lymphoma: A randomized, single-blind, phase III clinical trial |
Shi, Yuankai;Zhang, Qingyuan;Hong, Xiaonan;Wang, Zhen;Gao, Yuhuan;Zou, Liqun;Cen, Hong;Gui, Lin;Li, Yufu;Feng, Jifeng;Wang, Zhao;Zhang, Mingzhi;Jin, Chuan;Zhang, Weihua;Hu, Jianda;Zheng, Chengyun;Zheng, Zhendong;Zhang, Liling;Chen, Shaoshui;Huang, Yunhong;Tang, Yun;Gao, Yajie;Hao, Miaowang;Li, Xiaoling;Chang, Chunkang;Yang, Haiyan;Wu, Hui;Shen, Lida;Ke, Xiaoyan;Zhang, Liangming;Xi, Yaming;Yang, Linhua;Xie, Liangzhi;Gai, Wenlin;Ji, Yanan |
15-Nov-2022 |
Study of the Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas |
Ma, Jun;Song, Yuqin;Xie, Yan;Zhang, Hui-Lai;Shuang, Yuerong;Peng, Zhigang;Fei, Li;Huang, Yunhong;Zhao, Weili;Huang, Wenrong;Pan, Yali;Liu, Mingying;Ran, Feiwu;Feng, Hui;Yao, Sheng;Keegan, Patricia;Zou, Jianjun;Zhu, Jun |
20-Nov-2020 |
Synthesis of Heterobiaryl 4-Aryl Furans through a Base-Promoted Decarboxylative Propargylation/Cycloisomerization Annulation |
Wang, Sasa;Song, Meimei;Li, Xiuguang;Huang, Yunhong;Zhao, Tingxiang;Wei, Zhuoji;Lan, Yanyun;Tan, Haibo |